Novartis, Roche fined $526M in France for alleged Lucentis marketing missteps

Six years ago, the French Competition Authority raided the local offices of Roche and Novartis in search of evidence of missteps in the way the companies were marketing Lucentis for age-related macular degeneration (AMD).